Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Research Report 2022 Professional Edition
- HNY4739065
- 128 Pages
- January 2022
- Pharmaceuticals
The prime objective of this report is to provide the insights on the post COVID-19 impact wwhich will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Irritable bowel syndrome (IBS) is a common disorder that affects the large intestine. Signs and symptoms include cramping, abdominal pain, bloating, gas, and diarrhea or constipation, or both. IBS is a chronic condition that need to manage long term.IBS that causes increased diarrhea is often called IBS-D. Diarrhea predominant irritable bowel syndrome (IBS-D) is a subtype of IBS in which a person experiences frequent episodes of diarrhea with accompanying abdominal pain. Like IBS, IBS-D is a functional gastrointestinal disorder (FGD) in that there is no visible disease, inflammation, or injury to account for its symptoms. It is estimated that approximately a third of people who have IBS experience the disorder with diarrhea as the predominant bowel habit. In this report, we study the drugs for diarrhea predominant irritable bowel syndrome (IBS-D). North America is the largest consumption place of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs, followed by Europe. The two account for more than 80% of the consumer market in together. The most used IBS-D drug is XIFAXAN, accounting for more than 60% of the market share, followed by Viberzi and Lotronex. IBS-D drugs are widely sold through hospital pharmacies and retail pharmacies.
By Market Verdors:
Bausch Health
Allergan
Sebela Pharmaceuticals
Astellas Pharmaceuticals
Amneal Pharms
Pharscin Pharma
By Types:
XIFAXAN
Viberzi
Lotronex
By Applications:
Application A
Application B
Others
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue
1.4 Market Analysis by Type
1.4.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 XIFAXAN
1.4.3 Viberzi
1.4.4 Lotronex
1.5 Market by Application
1.5.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Application: 2022-2027
1.5.2 Application A
1.5.3 Application B
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market
1.8.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Market Share by Region (2016-2021)
3.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Revenue Market Share by Region (2016-2021)
3.3 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume
3.3.1 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Growth Rate (2016-2021)
3.3.2 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume
3.4.1 East Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume (2016-2021)
3.5.1 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume (2016-2021)
3.6.1 South Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume (2016-2021)
3.7.1 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume (2016-2021)
3.8.1 Middle East Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume (2016-2021)
3.9.1 Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume (2016-2021)
3.10.1 Oceania Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume (2016-2021)
3.11.1 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Growth Rate (2016-2021)
3.11.2 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume (2016-2021)
3.12.1 Rest of the World Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Market Share by Type (2016-2021)
14.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Revenue Market Share by Type (2016-2021)
14.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Volume by Application (2016-2021)
15.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business
16.1 Bausch Health
16.1.1 Bausch Health Company Profile
16.1.2 Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Specification
16.1.3 Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 Allergan
16.2.1 Allergan Company Profile
16.2.2 Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Specification
16.2.3 Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 Sebela Pharmaceuticals
16.3.1 Sebela Pharmaceuticals Company Profile
16.3.2 Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Specification
16.3.3 Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 Astellas Pharmaceuticals
16.4.1 Astellas Pharmaceuticals Company Profile
16.4.2 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Specification
16.4.3 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 Amneal Pharms
16.5.1 Amneal Pharms Company Profile
16.5.2 Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Specification
16.5.3 Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 Pharscin Pharma
16.6.1 Pharscin Pharma Company Profile
16.6.2 Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Specification
16.6.3 Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Cost Analysis
17.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
17.4 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Distributors List
18.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs (2022-2027)
20.2 Global Forecasted Revenue of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs (2022-2027)
20.3 Global Forecasted Price of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs (2016-2027)
20.4 Global Forecasted Production of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Region (2022-2027)
20.4.1 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue Forecast (2022-2027)
20.4.3 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue Forecast (2022-2027)
20.4.7 Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue Forecast (2022-2027)
20.4.9 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Country
21.2 East Asia Market Forecasted Consumption of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Country
21.3 Europe Market Forecasted Consumption of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Countriy
21.4 South Asia Forecasted Consumption of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Country
21.5 Southeast Asia Forecasted Consumption of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Country
21.6 Middle East Forecasted Consumption of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Country
21.7 Africa Forecasted Consumption of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Country
21.8 Oceania Forecasted Consumption of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Country
21.9 South America Forecasted Consumption of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Country
21.10 Rest of the world Forecasted Consumption of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Type (US$ Million): 2022-2027
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Application (US$ Million): 2022-2027
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity by Manufacturers
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production by Manufacturers (2016-2021)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Market Share by Manufacturers (2016-2021)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Manufacturers (2016-2021)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Manufacturers (2016-2021)
Global Market Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Price of Key Manufacturers (2016-2021)
Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Sites and Area Served
Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Type
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume by Region (2016-2021)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Market Share by Region (2016-2021)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Revenue by Region (2016-2021)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Revenue Market Share by Region (2016-2021)
North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
East Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
South Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Middle East Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Oceania Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Rest of the World Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption by Countries (2016-2021)
East Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption by Countries (2016-2021)
Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption by Region (2016-2021)
South Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption by Countries (2016-2021)
Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption by Countries (2016-2021)
Middle East Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption by Countries (2016-2021)
Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption by Countries (2016-2021)
Oceania Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption by Countries (2016-2021)
South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption by Countries (2016-2021)
Rest of the World Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption by Countries (2016-2021)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume by Type (2016-2021)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Market Share by Type (2016-2021)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Revenue by Type (2016-2021)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Revenue Share by Type (2016-2021)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price by Type (2016-2021)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Volume by Application (2016-2021)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Volume Market Share by Application (2016-2021)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Value by Application (2016-2021)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Value Market Share by Application (2016-2021)
Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Distributors List
Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Customers List
Market Key Trends
Key Opportunities and Drivers: Impact Analysis (2022-2027)
Key Challenges
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Forecast by Region (2022-2027)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Forecast by Type (2022-2027)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Market Share Forecast by Type (2022-2027)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Revenue Forecast by Type (2022-2027)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Revenue Market Share Forecast by Type (2022-2027)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price Forecast by Type (2022-2027)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Volume Forecast by Application (2022-2027)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Value Forecast by Application (2022-2027)
North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2022-2027 by Country
East Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2022-2027 by Country
Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2022-2027 by Country
South Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2022-2027 by Country
Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2022-2027 by Country
Middle East Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2022-2027 by Country
Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2022-2027 by Country
Oceania Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2022-2027 by Country
South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2022-2027 by Country
Rest of the world Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2022-2027 by Country
Research Programs/Design for This Report
Key Data Information from Secondary Sources
Key Data Information from Primary Sources
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Type: 2021 VS 2027
XIFAXAN Features
Viberzi Features
Lotronex Features
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Application: 2021 VS 2027
Application A Case Studies
Application B Case Studies
Others Case Studies
Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Report Years Considered
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Status and Outlook (2016-2027)
North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2016-2027)
East Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2016-2027)
Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2016-2027)
South Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2016-2027)
South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2016-2027)
Middle East Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2016-2027)
Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2016-2027)
Oceania Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2016-2027)
South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2016-2027)
Rest of the World Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2016-2027)
North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Growth Rate (2016-2021)
East Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Growth Rate (2016-2021)
Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Growth Rate (2016-2021)
South Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Growth Rate (2016-2021)
Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Growth Rate (2016-2021)
Middle East Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Growth Rate (2016-2021)
Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Growth Rate (2016-2021)
Oceania Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Growth Rate (2016-2021)
South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Growth Rate (2016-2021)
Rest of the World Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Growth Rate (2016-2021)
North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Market Share by Countries in 2021
United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
Canada Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
Mexico Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
East Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
East Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Market Share by Countries in 2021
China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
South Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate
Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Market Share by Region in 2021
Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
United Kingdom Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
Russia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
Spain Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
Netherlands Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
Switzerland Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
Poland Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
South Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate
South Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Market Share by Countries in 2021
India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
Pakistan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
Bangladesh Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate
Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Market Share by Countries in 2021
Indonesia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
Thailand Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
Singapore Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
Malaysia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
Philippines Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
Vietnam Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
Myanmar Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
Middle East Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate
Middle East Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Market Share by Countries in 2021
Turkey Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
Saudi Arabia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
Iran Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
United Arab Emirates Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
Israel Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
Iraq Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
Qatar Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
Kuwait Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
Oman Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate
Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Market Share by Countries in 2021
Nigeria Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
South Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
Egypt Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
Algeria Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
Morocco Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
Oceania Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate
Oceania Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Market Share by Countries in 2021
Australia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
New Zealand Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate
South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Market Share by Countries in 2021
Brazil Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
Argentina Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
Columbia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
Chile Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
Venezuelal Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
Peru Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
Puerto Rico Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
Ecuador Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
Rest of the World Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate
Rest of the World Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Market Share by Countries in 2021
Kazakhstan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2016-2021)
Sales Market Share of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Type in 2021
Sales Revenue Market Share of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Type in 2021
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Volume Market Share by Application in 2021
Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Specification
Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Specification
Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Specification
Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Specification
Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Specification
Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Specification
Manufacturing Cost Structure of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Manufacturing Process Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industrial Chain Analysis
Channels of Distribution
Distributors Profiles
Porter's Five Forces Analysis
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity Growth Rate Forecast (2022-2027)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate Forecast (2022-2027)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price and Trend Forecast (2016-2027)
North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate Forecast (2022-2027)
North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate Forecast (2022-2027)
East Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate Forecast (2022-2027)
East Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate Forecast (2022-2027)
Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate Forecast (2022-2027)
Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate Forecast (2022-2027)
South Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate Forecast (2022-2027)
South Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate Forecast (2022-2027)
Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate Forecast (2022-2027)
Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate Forecast (2022-2027)
Middle East Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate Forecast (2022-2027)
Middle East Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate Forecast (2022-2027)
Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate Forecast (2022-2027)
Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate Forecast (2022-2027)
Oceania Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate Forecast (2022-2027)
Oceania Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate Forecast (2022-2027)
South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate Forecast (2022-2027)
South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate Forecast (2022-2027)
Rest of the World Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate Forecast (2022-2027)
Rest of the World Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate Forecast (2022-2027)
North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2022-2027
East Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2022-2027
Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2022-2027
South Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2022-2027
Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2022-2027
Middle East Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2022-2027
Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2022-2027
Oceania Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2022-2027
South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2022-2027
Rest of the world Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2022-2027
Bottom-up and Top-down Approaches for This Report
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
